Clinical Outcomes among Hospitalized COVID-19 Patients Who Received Baricitinib or Tocilizumab in Addition to Standard of Care
Article in Diseases (May 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Evaluation of IFNAR2 and TYK2 transcripts’ prognostic role in COVID-19 patients: a retrospective study
Article in Frontiers in Cellular and Infection Microbiology (April 2024)
Efficacy of interleukin-6 inhibitors as a tool for preventive anti-inflammatory therapy for COVID-19
Article in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice (April 2024)